US Stock MarketDetailed Quotes

MYMD MyMD Pharmaceuticals

Watchlist

2.020
+0.020+1.00%

Trading May 23 09:30 ET

4.66MMarket Cap-217P/E (TTM)

MyMD Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

52.37%2.78M

7.05%16.36M

28.90%4.91M

3.58%3.84M

58.71%5.78M

-55.66%1.83M

-45.81%15.28M

21.81%3.81M

-15.84%3.71M

-80.03%3.64M

Selling and administrative expenses

50.01%1.59M

36.64%8.49M

45.63%1.95M

1.24%1.93M

140.51%3.56M

-29.16%1.06M

-71.03%6.22M

-44.26%1.34M

33.45%1.91M

-91.08%1.48M

-General and administrative expense

50.01%1.59M

36.64%8.49M

45.63%1.95M

1.24%1.93M

140.51%3.56M

-29.16%1.06M

-71.03%6.22M

-44.26%1.34M

33.45%1.91M

-91.08%1.48M

Research and development costs

55.62%1.2M

-13.23%7.87M

19.84%2.96M

6.05%1.91M

2.79%2.22M

-70.70%770.43K

34.43%9.07M

240.03%2.47M

-39.48%1.8M

30.26%2.16M

Operating profit

-52.37%-2.78M

-7.05%-16.36M

-28.90%-4.91M

-3.58%-3.84M

-58.71%-5.78M

55.66%-1.83M

45.81%-15.28M

-21.81%-3.81M

15.84%-3.71M

80.03%-3.64M

Net non-operating interest income expense

-29.11%18.31K

442.40%455.57K

85.54%115.84K

799.86%139.06K

2,821.00%174.85K

21,420.00%25.82K

114.01%83.99K

-33.71%62.43K

801.58%15.45K

117.16%5.99K

Non-operating interest income

-29.11%18.31K

442.40%455.57K

85.54%115.84K

799.86%139.06K

2,821.00%174.85K

21,420.00%25.82K

842.98%83.99K

3,922.68%62.43K

801.58%15.45K

6.12%5.99K

Other net income (expense)

-2,526.02%-7.03M

828,917.97%11.9M

2,729,242.70%2.43M

1,108,129.76%7.75M

151,706.75%1.44M

96,743.00%289.93K

100.13%1.44K

100.04%89

100.07%699

-99.47%948

Gain on sale of security

-768.12%-7.03M

427,436.33%12.85M

51,116.83%2.43M

417,236.70%7.93M

151,706.75%1.44M

22,300.82%1.05M

5.94%-3.01K

-112.11%-4.76K

279.83%1.9K

102.29%948

Earnings from equity interest

----

58.33%-500

----

27.27%-1.2K

----

Special income (charges)

--0

-21,284.87%-941.03K

--0

---178.2K

--0

-17,273.21%-762.83K

100.41%4.44K

--0

-Less:Other special charges

----

21,284.87%941.03K

--0

--178.2K

----

17,273.21%762.83K

-100.41%-4.44K

--0

----

Income before tax

-548.27%-9.8M

73.68%-4M

36.90%-2.36M

209.46%4.04M

-14.62%-4.17M

63.33%-1.51M

49.15%-15.2M

-15.61%-3.75M

32.44%-3.69M

79.90%-3.64M

Income tax

Net income

-548.27%-9.8M

73.68%-4M

36.90%-2.36M

209.46%4.04M

-14.62%-4.17M

63.33%-1.51M

49.15%-15.2M

-15.61%-3.75M

32.44%-3.69M

79.90%-3.64M

Net income continuous Operations

-548.27%-9.8M

73.68%-4M

36.90%-2.36M

209.46%4.04M

-14.62%-4.17M

63.33%-1.51M

49.15%-15.2M

-15.61%-3.75M

32.44%-3.69M

79.90%-3.64M

Minority interest income

Net income attributable to the parent company

-548.27%-9.8M

73.68%-4M

36.90%-2.36M

209.46%4.04M

-14.62%-4.17M

63.33%-1.51M

49.15%-15.2M

-15.61%-3.75M

32.44%-3.69M

79.90%-3.64M

Preferred stock dividends

659.08%1.2M

4.22M

2.53M

1.16M

373.8K

158.33K

Other preferred stock dividends

Net income attributable to common stockholders

-558.77%-11M

45.92%-8.22M

-30.60%-4.89M

178.10%2.88M

-24.90%-4.54M

59.48%-1.67M

49.15%-15.2M

-15.61%-3.75M

32.44%-3.69M

79.90%-3.64M

Basic earnings per share

-328.33%-5.14

54.60%-5.33

-6.94%-2.93

166.67%1.8

-22.22%-3.3

63.64%-1.2

53.96%-11.74

-30.48%-2.74

40.00%-2.7

82.00%-2.7

Diluted earnings per share

-328.33%-5.14

54.60%-5.33

-6.94%-2.93

166.67%1.8

-22.22%-3.3

63.64%-1.2

53.96%-11.74

-30.48%-2.74

40.00%-2.7

82.00%-2.7

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue	0	0	0	0	0	0	0	0	0	0
Gross profit	0	0	0	0	0	0	0	0	0	0
Operating expense	52.37%2.78M	7.05%16.36M	28.90%4.91M	3.58%3.84M	58.71%5.78M	-55.66%1.83M	-45.81%15.28M	21.81%3.81M	-15.84%3.71M	-80.03%3.64M
Selling and administrative expenses	50.01%1.59M	36.64%8.49M	45.63%1.95M	1.24%1.93M	140.51%3.56M	-29.16%1.06M	-71.03%6.22M	-44.26%1.34M	33.45%1.91M	-91.08%1.48M
-General and administrative expense	50.01%1.59M	36.64%8.49M	45.63%1.95M	1.24%1.93M	140.51%3.56M	-29.16%1.06M	-71.03%6.22M	-44.26%1.34M	33.45%1.91M	-91.08%1.48M
Research and development costs	55.62%1.2M	-13.23%7.87M	19.84%2.96M	6.05%1.91M	2.79%2.22M	-70.70%770.43K	34.43%9.07M	240.03%2.47M	-39.48%1.8M	30.26%2.16M
Operating profit	-52.37%-2.78M	-7.05%-16.36M	-28.90%-4.91M	-3.58%-3.84M	-58.71%-5.78M	55.66%-1.83M	45.81%-15.28M	-21.81%-3.81M	15.84%-3.71M	80.03%-3.64M
Net non-operating interest income expense	-29.11%18.31K	442.40%455.57K	85.54%115.84K	799.86%139.06K	2,821.00%174.85K	21,420.00%25.82K	114.01%83.99K	-33.71%62.43K	801.58%15.45K	117.16%5.99K
Non-operating interest income	-29.11%18.31K	442.40%455.57K	85.54%115.84K	799.86%139.06K	2,821.00%174.85K	21,420.00%25.82K	842.98%83.99K	3,922.68%62.43K	801.58%15.45K	6.12%5.99K
Other net income (expense)	-2,526.02%-7.03M	828,917.97%11.9M	2,729,242.70%2.43M	1,108,129.76%7.75M	151,706.75%1.44M	96,743.00%289.93K	100.13%1.44K	100.04%89	100.07%699	-99.47%948
Gain on sale of security	-768.12%-7.03M	427,436.33%12.85M	51,116.83%2.43M	417,236.70%7.93M	151,706.75%1.44M	22,300.82%1.05M	5.94%-3.01K	-112.11%-4.76K	279.83%1.9K	102.29%948
Earnings from equity interest	----	----	----	58.33%-500	----	----	----	----	27.27%-1.2K	----
Special income (charges)	--0	-21,284.87%-941.03K	--0	---178.2K	--0	-17,273.21%-762.83K	100.41%4.44K	--0	--0	--0
-Less:Other special charges	----	21,284.87%941.03K	--0	--178.2K	----	17,273.21%762.83K	-100.41%-4.44K	--0	----	----
Income before tax	-548.27%-9.8M	73.68%-4M	36.90%-2.36M	209.46%4.04M	-14.62%-4.17M	63.33%-1.51M	49.15%-15.2M	-15.61%-3.75M	32.44%-3.69M	79.90%-3.64M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-548.27%-9.8M	73.68%-4M	36.90%-2.36M	209.46%4.04M	-14.62%-4.17M	63.33%-1.51M	49.15%-15.2M	-15.61%-3.75M	32.44%-3.69M	79.90%-3.64M
Net income continuous Operations	-548.27%-9.8M	73.68%-4M	36.90%-2.36M	209.46%4.04M	-14.62%-4.17M	63.33%-1.51M	49.15%-15.2M	-15.61%-3.75M	32.44%-3.69M	79.90%-3.64M
Minority interest income
Net income attributable to the parent company	-548.27%-9.8M	73.68%-4M	36.90%-2.36M	209.46%4.04M	-14.62%-4.17M	63.33%-1.51M	49.15%-15.2M	-15.61%-3.75M	32.44%-3.69M	79.90%-3.64M
Preferred stock dividends	659.08%1.2M	4.22M	2.53M	1.16M	373.8K	158.33K
Other preferred stock dividends
Net income attributable to common stockholders	-558.77%-11M	45.92%-8.22M	-30.60%-4.89M	178.10%2.88M	-24.90%-4.54M	59.48%-1.67M	49.15%-15.2M	-15.61%-3.75M	32.44%-3.69M	79.90%-3.64M
Basic earnings per share	-328.33%-5.14	54.60%-5.33	-6.94%-2.93	166.67%1.8	-22.22%-3.3	63.64%-1.2	53.96%-11.74	-30.48%-2.74	40.00%-2.7	82.00%-2.7
Diluted earnings per share	-328.33%-5.14	54.60%-5.33	-6.94%-2.93	166.67%1.8	-22.22%-3.3	63.64%-1.2	53.96%-11.74	-30.48%-2.74	40.00%-2.7	82.00%-2.7
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall